Academic patents and access to medicines in developing countries

Area of Science:

• Biomedical ethics
• Intellectual property law
• Global health policy

Background:

• Growing concern exists that patents impede access to essential medicines in developing countries.
• Student movements and legislative efforts highlight the potential role of research universities in bridging this
• access gap
• .

Purpose of the Study:

• To empirically investigate the extent to which universities hold patents on drugs and file them in developing countries.
• To explore the feasibility and desirability of modifying university patenting and licensing strategies to improve medicine access in the developing world.

Main Methods:

• Analysis of university patent ownership data.
• Examination of patent filing locations for pharmaceutical products.
• Assessment of proposed changes to university intellectual property policies.

Main Results:

• Preliminary findings suggest that the assumption of widespread university patenting of drugs in developing countries may be overstated.
• The actual impact of university patenting on medicine access in these regions requires further nuanced investigation.

Conclusions:

• University patenting practices may not be the primary driver of the
• access gap
• for essential medicines.
• Policy discussions should consider a broader range of factors influencing drug accessibility beyond university-owned patents.